The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up
scientific article published on 14 January 2009
Author/s
author: Serena Merante, Fabio Stagno, Francesca Palandri, Nicoletta Testoni, Giorgina Specchia, Giuseppe Saglio, Gianantonio Rosti, Fausto Castagnetti, Giuliana Alimena, Giovanni Martinelli, Michele Baccarani, Massimo Breccia, Simona Luatti, Bruno Martino, Fabrizio Pane, Giovanna Rege Cambrin, Luciano Levato
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.